Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shilpa Grover

Showing results (41-50 of 48) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 48 results.
Journal of Immunotherapy and Precision Oncology|June 6, 2022
Impact of COVID-19 on Patients with Cancer Receiving Immune Checkpoint InhibitorsAi-Tram N Bui, Kevin Tyan, Anita Giobbie-Hurder, et al.
Journal for Immunotherapy of Cancer|August 21, 2020
Novel platform leveraging electronic medical record (EMR) to triage patients admitted with high-grade immune-related adverse events (irAEs) to the immune-toxicity (ITOX) serviceOsama Abu-Shawer, Prabhsimranjot Singh, Eric Yenulevich, et al.
JCO Oncology Practice|May 14, 2020
Safety of Immune Checkpoint Inhibitors in Patients With Pre-Existing Inflammatory Bowel Disease and Microscopic ColitisShilpa Grover, Alex B Ruan, Padmavathi Srivoleti, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 22, 2009
Colorectal cancer risk perception on the basis of genetic test results in individuals at risk for Lynch syndromeShilpa Grover, Elena M Stoffel, Rowena C Mercado, et al.
Gastro Hep Advances|October 27, 2025
Recent Abdominal Surgery as a Risk Factor for Unfavorable Immune-Mediated Colitis OutcomesRohan Ahuja, Malek Shatila, Jay Shah, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|June 18, 2025
Worse Survival and Gastrointestinal Toxicity Outcomes Among Patients Receiving Proton Pump Inhibitors During Checkpoint Inhibitor TherapyMalek Shatila, Samanthika Devalaraju, Kei Takigawa, et al.
Cancer|June 23, 2020
Vitamin D intake is associated with decreased risk of immune checkpoint inhibitor-induced colitisShilpa Grover, Michael Dougan, Kevin Tyan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 3, 2024
Enhancing Precision in Detecting Severe Immune-Related Adverse Events: Comparative Analysis of Large Language Models and International Classification of Disease Codes in Patient RecordsVirginia H Sun, Julius C Heemelaar, Ibrahim Hadzic, et al.
Pageof 5

Showing results (41-50 of 48) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 48 results.
Journal of Immunotherapy and Precision Oncology|June 6, 2022
Impact of COVID-19 on Patients with Cancer Receiving Immune Checkpoint InhibitorsAi-Tram N Bui, Kevin Tyan, Anita Giobbie-Hurder, et al.
Journal for Immunotherapy of Cancer|August 21, 2020
Novel platform leveraging electronic medical record (EMR) to triage patients admitted with high-grade immune-related adverse events (irAEs) to the immune-toxicity (ITOX) serviceOsama Abu-Shawer, Prabhsimranjot Singh, Eric Yenulevich, et al.
JCO Oncology Practice|May 14, 2020
Safety of Immune Checkpoint Inhibitors in Patients With Pre-Existing Inflammatory Bowel Disease and Microscopic ColitisShilpa Grover, Alex B Ruan, Padmavathi Srivoleti, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 22, 2009
Colorectal cancer risk perception on the basis of genetic test results in individuals at risk for Lynch syndromeShilpa Grover, Elena M Stoffel, Rowena C Mercado, et al.
Gastro Hep Advances|October 27, 2025
Recent Abdominal Surgery as a Risk Factor for Unfavorable Immune-Mediated Colitis OutcomesRohan Ahuja, Malek Shatila, Jay Shah, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|June 18, 2025
Worse Survival and Gastrointestinal Toxicity Outcomes Among Patients Receiving Proton Pump Inhibitors During Checkpoint Inhibitor TherapyMalek Shatila, Samanthika Devalaraju, Kei Takigawa, et al.
Cancer|June 23, 2020
Vitamin D intake is associated with decreased risk of immune checkpoint inhibitor-induced colitisShilpa Grover, Michael Dougan, Kevin Tyan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 3, 2024
Enhancing Precision in Detecting Severe Immune-Related Adverse Events: Comparative Analysis of Large Language Models and International Classification of Disease Codes in Patient RecordsVirginia H Sun, Julius C Heemelaar, Ibrahim Hadzic, et al.
Pageof 5